Pharmacokinetic and clinical improvements after PK-guided switch from standard half-life to extended half-life factor VIII products.
Megías-Vericat JE, Bonanad Boix S, Berrueco Moreno R, Mingot-Castellano ME, Rodríguez López M, Canaro Hirnyk M, Mateo Arranz J, Calvo Villas JM, Haya Guaita S, Mesegué Medà M, López Jaime F, Albo-López C, Palomero-Massanet A, Vilalta Seto N, Leciñena IL, Haro ARC, Poveda Andrés JL.
Megías-Vericat JE, et al.
Thromb Res. 2022 Aug;216:35-42. doi: 10.1016/j.thromres.2022.06.001. Epub 2022 Jun 7.
Thromb Res. 2022.
PMID: 35696967
No abstract available.